Biotech Sets $75M IPO Terms While Another Yanks Deal
Immuno-oncology treatment developer Corvus Pharmaceuticals Inc. set terms for a $75 million initial public offering Thursday, while private equity-backed insulin device maker Valeritas Inc. pulled its planned float of the same...To view the full article, register now.
Already a subscriber? Click here to view full article